Tirzepatide is a novel agent that acts as an agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, another incretin that lowers glucose and appetite
But concentrated solutions (10mg/ml or higher) should display obvious blue coloration
The CDC states that an opened repeated-entry vial should be dated and discarded within 28 days unless the manufacturer states another period
license suspended, Canadian Broadcasting Corporation (2023) Personal importation, Food and Drug Administration (2024) Save on Ozempic (semaglutide) injection, Novo Nordisk FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2025) Internet pharmacy warning letters, Food & Drug Administration (2025) How to buy medicines safely from an online pharmacy, Food & Drug Administration (2025) Supply of Ozempic and other GLP-1 receptor agonists: Notice, Government of Canada (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food & Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Your health journey matters.
